Kelly Abernethy

Kelly Abernethy is an accomplished professional in the pharmaceutical and product development sectors, currently serving as the Director of Execution at Exela Pharma Sciences LLC since August 2023 and as a Product Development Scientist at SynergyLabs since July 2022. With a significant tenure at Exela Pharma Sciences LLC from September 2009 to June 2022, Kelly held various leadership roles including Director of Research and Development and Associate Director of Research and Development. Academic credentials include a Master's degree in Chemistry and a Bachelor of Science in Chemistry, both obtained from Western Carolina University.